Advocacy at a Glance Guest User 1/10/15 Advocacy at a Glance Guest User 1/10/15 Food Safety Regulatory Agenda for 2015 and more Read More Analysis and Commentary Guest User 12/19/14 Analysis and Commentary Guest User 12/19/14 FY 2016: Out with the Old; In with the New Read More Advocacy at a Glance Guest User 12/19/14 Advocacy at a Glance Guest User 12/19/14 FY 15 Appropriations Completed and more Read More Uncategorized Guest User 12/12/14 Uncategorized Guest User 12/12/14 The “Consolidated and Further Continuing Appropriations Act, 2015” Read More Analysis and Commentary Guest User 12/5/14 Analysis and Commentary Guest User 12/5/14 Why Unfunded Mandates Can Be a Real Problem for FDA Read More Advocacy at a Glance Guest User 12/5/14 Advocacy at a Glance Guest User 12/5/14 Appropriations Funding Deal Nearly in Place and more Read More Analysis and Commentary Guest User 11/20/14 Analysis and Commentary Guest User 11/20/14 "Turkey Day" ... and an Expression of Gratitude Read More Advocacy at a Glance Guest User 11/21/14 Advocacy at a Glance Guest User 11/21/14 Fate of FY 15 Appropriations Still Unresolved and more Read More Analysis and Commentary Guest User 11/14/14 Analysis and Commentary Guest User 11/14/14 "Fiscal Cliffs" and Life in "Interesting Times" Read More Advocacy at a Glance Guest User 11/14/14 Advocacy at a Glance Guest User 11/14/14 Lawmakers Return to Washington as Lame-Duck Session Begins and more Read More Analysis and Commentary Guest User 11/7/14 Analysis and Commentary Guest User 11/7/14 Change Is Unsettling ... But Our Message Remains the Same Read More Advocacy at a Glance Guest User 11/7/14 Advocacy at a Glance Guest User 11/7/14 Election Results: New Republican Senate Majority, Expanded Republican House Majority and more Read More Advocacy at a Glance Guest User 10/31/14 Advocacy at a Glance Guest User 10/31/14 Ebola: FDA On the Job and more Read More Analysis and Commentary Guest User 10/31/14 Analysis and Commentary Guest User 10/31/14 Planning for a Late Night Watching "the Box" Read More Analysis and Commentary Guest User 10/24/14 Analysis and Commentary Guest User 10/24/14 FDA Can't Just Pare Back Without Risk for Harm Read More Advocacy at a Glance Guest User 10/24/14 Advocacy at a Glance Guest User 10/24/14 FDA Approves 34 NME Drugs So Far in 2014 and more Read More Analysis and Commentary Guest User 10/18/14 Analysis and Commentary Guest User 10/18/14 Appropriators Are the First Priority, But ... Read More Advocacy at a Glance Guest User 10/18/14 Advocacy at a Glance Guest User 10/18/14 Alliance Holds “FDA 101” Hill Briefing and more Read More Analysis and Commentary Guest User 10/10/14 Analysis and Commentary Guest User 10/10/14 When Tough Choices Get Made, FDA Will Prevail Read More Advocacy at a Glance Guest User 10/10/14 Advocacy at a Glance Guest User 10/10/14 Alliance Launches Planned Series of Hill “FDA 101” Briefings and more Read More Newer Posts Older Posts
Advocacy at a Glance Guest User 1/10/15 Advocacy at a Glance Guest User 1/10/15 Food Safety Regulatory Agenda for 2015 and more Read More
Analysis and Commentary Guest User 12/19/14 Analysis and Commentary Guest User 12/19/14 FY 2016: Out with the Old; In with the New Read More
Advocacy at a Glance Guest User 12/19/14 Advocacy at a Glance Guest User 12/19/14 FY 15 Appropriations Completed and more Read More
Uncategorized Guest User 12/12/14 Uncategorized Guest User 12/12/14 The “Consolidated and Further Continuing Appropriations Act, 2015” Read More
Analysis and Commentary Guest User 12/5/14 Analysis and Commentary Guest User 12/5/14 Why Unfunded Mandates Can Be a Real Problem for FDA Read More
Advocacy at a Glance Guest User 12/5/14 Advocacy at a Glance Guest User 12/5/14 Appropriations Funding Deal Nearly in Place and more Read More
Analysis and Commentary Guest User 11/20/14 Analysis and Commentary Guest User 11/20/14 "Turkey Day" ... and an Expression of Gratitude Read More
Advocacy at a Glance Guest User 11/21/14 Advocacy at a Glance Guest User 11/21/14 Fate of FY 15 Appropriations Still Unresolved and more Read More
Analysis and Commentary Guest User 11/14/14 Analysis and Commentary Guest User 11/14/14 "Fiscal Cliffs" and Life in "Interesting Times" Read More
Advocacy at a Glance Guest User 11/14/14 Advocacy at a Glance Guest User 11/14/14 Lawmakers Return to Washington as Lame-Duck Session Begins and more Read More
Analysis and Commentary Guest User 11/7/14 Analysis and Commentary Guest User 11/7/14 Change Is Unsettling ... But Our Message Remains the Same Read More
Advocacy at a Glance Guest User 11/7/14 Advocacy at a Glance Guest User 11/7/14 Election Results: New Republican Senate Majority, Expanded Republican House Majority and more Read More
Advocacy at a Glance Guest User 10/31/14 Advocacy at a Glance Guest User 10/31/14 Ebola: FDA On the Job and more Read More
Analysis and Commentary Guest User 10/31/14 Analysis and Commentary Guest User 10/31/14 Planning for a Late Night Watching "the Box" Read More
Analysis and Commentary Guest User 10/24/14 Analysis and Commentary Guest User 10/24/14 FDA Can't Just Pare Back Without Risk for Harm Read More
Advocacy at a Glance Guest User 10/24/14 Advocacy at a Glance Guest User 10/24/14 FDA Approves 34 NME Drugs So Far in 2014 and more Read More
Analysis and Commentary Guest User 10/18/14 Analysis and Commentary Guest User 10/18/14 Appropriators Are the First Priority, But ... Read More
Advocacy at a Glance Guest User 10/18/14 Advocacy at a Glance Guest User 10/18/14 Alliance Holds “FDA 101” Hill Briefing and more Read More
Analysis and Commentary Guest User 10/10/14 Analysis and Commentary Guest User 10/10/14 When Tough Choices Get Made, FDA Will Prevail Read More
Advocacy at a Glance Guest User 10/10/14 Advocacy at a Glance Guest User 10/10/14 Alliance Launches Planned Series of Hill “FDA 101” Briefings and more Read More
